Creative Commons source reading · Women and female-athlete health
Tracking androgens in female elite athletes: menstrual cycle and hormonal contraceptive effects
Nolte J; Voss SC; Keiler AM; Büthe E; Legerlotz K; Platen P
Originally published in BMC Womens Health · 2026-03-13
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
AbstractBackgroundUnderstanding variations in the androgen profile is crucial for interpreting hormone data and developing cycle-based training strategies tailored to individual athlete needs. Therefore, this study investigates the androgen concentrations of elite female track and field athletes across various hormonal conditions, including natural eumenorrheic cycles, cycles under hormonal contraception, and cycles with menstrual disturbances.MethodsUsing a prospective, longitudinal observational cohort design, 22 athletes (15 naturally cycling, 7 using hormonal contraception) were monitored for up to three consecutive cycles. The study utilised daily or near-daily urine sampling to analyse urinary steroid hormones (including testosterone and its metabolites) via gas chromatography-coupled mass spectrometry (GC-MS/MS).ResultsResults…
Results
To examine phase-specific differences, we analysed ovulatory cycles (n = 26) and combined oral contraceptive (pill) cycles (n = 10). For group-specific comparisons, cycles were categorised as natural eumenorrheic (n = 15), menstrual disturbances (n = 11), oral contraceptive use (n = 10), and hormonal IUD use (n = 3). Menstrual disturbances comprised oligomenorrhea (n = 1), short luteal phase (n = 8), and luteal phase deficiency (n = 2). In athletes with ovulatory menstrual cycles without any hormonal contraceptive use (n = 26), urinary androgen concentrations varied by phase for testosterone, 5β-androstanedione, 5α-androstanediol, androsterone, and etiocholanolone (Fig. 4). Testosterone and 5α-androstanediol were significantly different in the lateFP compared with all other phases (p ≤ 0.05). 5β-Androstanedione showed a similar…
Discussion
To our knowledge, this study is the first to systematically investigate urinary steroid hormone profiles at a high frequency in competitive female athletes across distinct menstrual cycle conditions, including natural eumenorrheic cycles, cycles under hormonal contraception, and cycles with menstrual disturbances. In line with our hypothesis, androgen concentrations were significantly lower in athletes using exogenous hormonal contraception and appeared lower in athletes with menstrual cycle irregularities (not formally tested). In menstruating athletes with ovulation, we observed significantly higher androgen levels immediately prior to ovulation compared to other menstrual phases. These findings underscore the importance of considering individual androgen profiles and their variability when interpreting hormonal data in athletic…
Editorial reading guide
- Was the study designed for the population to which its conclusion is applied?
- What safeguard, access need or equity consequence should shape implementation?
